1. A white-knuckle ride of open COVID drug discovery.
- Author
-
von Delft F, Calmiano M, Chodera J, Griffen E, Lee A, London N, Matviuk T, Perry B, Robinson M, and von Delft A
- Subjects
- Animals, Antiviral Agents pharmacology, Antiviral Agents therapeutic use, COVID-19 epidemiology, COVID-19 virology, Clinical Trials as Topic, Coronavirus 3C Proteases antagonists & inhibitors, Coronavirus 3C Proteases chemistry, Crowdsourcing, Crystallography, X-Ray instrumentation, Drug Repositioning, Goals, Humans, International Cooperation, Israel epidemiology, SARS-CoV-2 genetics, SARS-CoV-2 isolation & purification, Social Media, Synchrotrons, Time Factors, United Kingdom epidemiology, Videoconferencing, Volunteers, World Health Organization organization & administration, Antiviral Agents analysis, Cooperative Behavior, Drug Discovery methods, Drug Discovery organization & administration, Drug Evaluation, Preclinical methods, Open Access Publishing, COVID-19 Drug Treatment
- Published
- 2021
- Full Text
- View/download PDF